These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6674267)

  • 1. Bone disease in uremia.
    Coburn JW
    Henry Ford Hosp Med J; 1983; 31(4):217-20. PubMed ID: 6674267
    [No Abstract]   [Full Text] [Related]  

  • 2. The treatment of metabolic bone disease in patients on peritoneal dialysis.
    Armstrong A; Cunningham J
    Kidney Int Suppl; 1994 Dec; 48():S51-7. PubMed ID: 7700042
    [No Abstract]   [Full Text] [Related]  

  • 3. [Current problems of azotemic bone diseases].
    Schaefer K; Opitz A
    Dtsch Med Wochenschr; 1970 Jan; 95(2):84-8. PubMed ID: 4902985
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical practice guidelines for bone metabolism and disease in chronic kidney disease: an overview.
    Bailie GR; Massry SG;
    Pharmacotherapy; 2005 Dec; 25(12):1687-707. PubMed ID: 16305288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrophosphate and diphosphonates in calcium metabolism and their possible role in renal failure.
    Russell RG; Bisaz S; Fleisch H
    Arch Intern Med; 1969 Nov; 124(5):571-7. PubMed ID: 4310762
    [No Abstract]   [Full Text] [Related]  

  • 6. Chronic kidney disease/bone and mineral metabolism: the imperfect storm.
    Williams ME
    Semin Nephrol; 2009 Mar; 29(2):97-104. PubMed ID: 19371800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Disorders of calcium metabolism in kidney failure].
    Ritz E; Krempien B; Andrassy K
    Med Klin; 1972 Sep; 67(36):1129-32. PubMed ID: 4561354
    [No Abstract]   [Full Text] [Related]  

  • 8. The spectrum of renal bone disease: introduction.
    LeBoff MS
    Semin Nephrol; 2009 Mar; 29(2):95-6. PubMed ID: 19371799
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspects of renal bone disease.
    Cochran M
    Aust N Z J Med; 1981; 11(Suppl 1):33-7. PubMed ID: 6942800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone diseases in uremia].
    Schulz W
    Med Welt; 1980 Oct; 31(43):1534-43. PubMed ID: 7007789
    [No Abstract]   [Full Text] [Related]  

  • 11. [Contributions of the software La Clé Concerto in the implementation of the NKF-K/DOQI (National Kidney Foundation-Kidney/Dialysis Outcomes Quality Initiative) recommendations for the control of mineral and bone metabolism disorders in the patient with chronic renal failure].
    Ureña P
    Nephrol Ther; 2008 Sep; 4 Spec No 1():9-14, 20-35. PubMed ID: 19031633
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monstrous tumourous changes of the facial bones in secondary hyperparathyroidism (author's transl)].
    Pfeifle J; Koch H; Grabensee B; Knieriem HI
    Dtsch Med Wochenschr; 1974 Mar; 99(9):389-91. PubMed ID: 4828634
    [No Abstract]   [Full Text] [Related]  

  • 13. Requirements of vitamin D metabolites in patients with renal disease.
    Massry SG
    Am J Clin Nutr; 1980 Jul; 33(7):1530-5. PubMed ID: 6893103
    [No Abstract]   [Full Text] [Related]  

  • 14. [Introduction. CKD-MBD (Chronic kidney disease-Metabolic bone disease)].
    Cozzolino M; Mazzaferro S
    G Ital Nefrol; 2009; 26 Suppl 49():S1. PubMed ID: 19941271
    [No Abstract]   [Full Text] [Related]  

  • 15. The hungry bone syndrome: clinical problems and therapeutic approaches following parathyroidectomy.
    Savazzi GM; Allegri L
    Eur J Med; 1993; 2(6):363-8. PubMed ID: 8252183
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular basis of parathyroid hyperplasia.
    Dusso AS; Arcidiacono MV; Sato T; Alvarez-Hernandez D; Yang J; Gonzalez-Suarez I; Tominaga Y; Slatopolsky E
    J Ren Nutr; 2007 Jan; 17(1):45-7. PubMed ID: 17198931
    [No Abstract]   [Full Text] [Related]  

  • 17. [Diet in the prevention of uremic osteodystrophy].
    Maschio G; D'Angelo A; Bonucci E; Tessitore N; Lo Schiavo C; Lupo A; Valvo E; Chiaramonte S; Previato G; Fabris A; Saporiti E; Fiaschi E
    G Clin Med; 1980 May; 61(5):358-64. PubMed ID: 7450355
    [No Abstract]   [Full Text] [Related]  

  • 18. The ultrastructural appearance of bone cells and bone matrix in renal osteodystrophy.
    Robinson RA
    Arch Intern Med; 1969 Nov; 124(5):519-29. PubMed ID: 5345858
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of long-term therapy with calcitriol in patients with moderate renal failure.
    Healy MD; Malluche HH; Goldstein DA; Singer FR; Massry SG
    Arch Intern Med; 1980 Aug; 140(8):1030-3. PubMed ID: 6893118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortions of bone cell metabolism in uremia and their cause.
    Nichols G; Flanagan B; Veer Jv
    Arch Intern Med; 1969 Nov; 124(5):530-8. PubMed ID: 5345859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.